Newborns receive a single intramuscular injection of vitamin K at birth to prevent vitamin K

Newborns receive a single intramuscular injection of vitamin K at birth to prevent vitamin K deficiency bleeding, a potentially life-threatening condition, according to medical guidance from the American Academy of Pediatrics and the European Standards of Care for Newborn Health. Despite this established standard, health and wellness influencers on social media are promoting claims that infant vitamin K deficiency is intentional and that the routine birth injection interferes with stem cell circulation. science.feedback.org reported that these scientifically unfounded claims misrepresent normal human coagulation biology and dismiss documented health risks to infants.

Social Media Claims Target Routine Newborn Care

Misinformation regarding infant vitamin K has spread across platforms like TikTok and X, contributing to a growing refusal of the birth injection by parents. Chiropractor Daniel Pompa shared a video on TikTok viewed more than 174,000 times claiming that low vitamin K levels keep infant blood naturally thin so stem cells can travel freely to repair the physical stress of birth. An X account, @ValerieAnne1970, shared similar claims that were viewed more than 116,000 times. science.feedback.org noted that these posts argue high clotting factors would trap precious stem cells necessary for brain development and other developmental needs.

Coagulation Biology and Clotting Cascades

The idea that vitamin K thickens blood and blocks stem cell movement stems from a misunderstanding of how the coagulation cascade works in the human body. Vitamin K alone is not sufficient to trigger blood clotting; instead, the body requires it to manufacture specific proteins known as clotting factors that participate in the cascade. The body also maintains active anti-clotting mechanisms to prevent spontaneous coagulation in the absence of an injury or bleed. These regulatory systems ensure that blood clotting remains strictly confined to sites of trauma, meaning a standard vitamin K injection cannot override normal physiological controls or impede stem cell migration.

Documented Risks of Untreated Deficiency

Newborn infants are naturally deficient in vitamin K because very little of the nutrient crosses the placenta, and the infant intestinal microbiome is too immature to produce it independently. While breast milk and formula provide small amounts of vitamin K, intake remains insufficient to prevent deficiency immediately after birth. Skipping the recommended 1 milligram intramuscular injection exposes infants to severe risks, including intracranial hemorrhage, permanent neurological damage, and death. Conversely, documented side effects from the injection are minor, limited mostly to temporary pain and swelling at the site, while severe allergic reactions are exceedingly rare.